{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:27:03Z","timestamp":1787315223227,"version":"build-2736575974"},"reference-count":71,"publisher":"Sociedad Espanola de Patologia Digestiva (SEPD)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev Esp Enferm Dig"],"published-print":{"date-parts":[[2026]]},"DOI":"10.17235\/reed.2026.11781\/2025","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T09:31:48Z","timestamp":1768555908000},"source":"Crossref","is-referenced-by-count":1,"title":["Left atrial appendage closure for atrial fibrillation patients at high risk of gastrointestinal bleeding. An evidence-based multidisciplinary review for gastroenterologists"],"prefix":"10.17235","author":[{"given":"Patricia","family":"Sanz Segura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Jimeno S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Senzolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Grygier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanesa","family":"Bernal-Monterde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"P\u00e9rez de Prado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. John","family":"Camm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6910","reference":[{"key":"ref1","unstructured":"Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation [Internet]. 2019 Mar 5 [cited 2024 Sep 17];139(10):e56\ufffd528. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30700139\/"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"2. \tLinz D, Gawalko M, Betz K, Hendriks JM, Lip GYH, Vinter N, et al. Atrial fibrillation: epidemiology, screening and digital health. Lancet Reg Heal Eur [Internet]. 2024 Feb 1 [cited 2024 Dec 9];37. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/38362546\/","DOI":"10.1016\/j.lanepe.2023.100786"},{"key":"ref3","unstructured":"3. \tVan Gelder IC, Rienstra M, Bunting K V, Casado-Arroyo R, Caso V, Crijns HJGM, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J [Internet]. 2024 Aug 30 [cited 2024 Sep 17]; Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39210723\/"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"4. \tLopes LC, Spencer FA, Neumann I, Ventresca M, Ebrahim S, Zhou Q, et al. Bleeding risk in atrial fibrillation patients taking vitamin K antagonists: systematic review and meta-analysis. Clin Pharmacol Ther [Internet]. 2013 Sep [cited 2024 Sep 17];94(3):367\ufffd75. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/23670121\/","DOI":"10.1038\/clpt.2013.99"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"5. \tHart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med [Internet]. 2007 Jun 5 [cited 2024 Dec 9];146(12):857\ufffd67. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/17577005\/","DOI":"10.7326\/0003-4819-146-12-200706190-00007"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"6. \tRuff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet (London, England) [Internet]. 2014 [cited 2024 Sep 17];383(9921):955\ufffd62. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/24315724\/","DOI":"10.1016\/S0140-6736(13)62343-0"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"7. \tTalasaz AH, Sadeghipour P, Ortega-Paz L, Kakavand H, Aghakouchakzadeh M, Beavers C, et al. Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease. Nat Rev Cardiol [Internet]. 2024 Aug 1 [cited 2024 Dec 9];21(8):574\ufffd92. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/38509244\/","DOI":"10.1038\/s41569-024-01003-3"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"8. \tLanas-Gimeno A, Lanas A. Risk of gastrointestinal bleeding during anticoagulant treatment. Expert Opin Drug Saf [Internet]. 2017 Jun 3 [cited 2024 Sep 17];16(6):673\ufffd85. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28467190\/","DOI":"10.1080\/14740338.2017.1325870"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"9. \tAbraham NS, Noseworthy PA, Yao X, Sangaralingham LR, Shah ND. Gastrointestinal Safety of Direct Oral Anticoagulants: A Large Population-Based Study. Gastroenterology [Internet]. 2017 Apr 1 [cited 2024 Sep 17];152(5):1014-1022.e1. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28043907\/","DOI":"10.1053\/j.gastro.2016.12.018"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"10. \tDeitelzweig S, Keshishian A, Kang A, Dhamane AD, Luo X, Balachander N, et al. Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patients. Therap Adv Gastroenterol [Internet]. 2021 [cited 2024 Dec 9];14. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33815568\/","DOI":"10.1177\/1756284821997352"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"11. \tPotpara T, Grygier M, H\u00e4usler KG, Nielsen-Kudsk JE, Berti S, Genovesi S, et al. Practical guide on left atrial appendage closure for the non-implanting physician: an international consensus paper. Europace [Internet]. 2024 Apr 1 [cited 2024 Sep 17];26(4). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/38291925\/","DOI":"10.1093\/europace\/euae142"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"12. \tLandmesser U, Skurk C, Tzikas A, Falk V, Reddy VY, Windecker S. Left atrial appendage closure for stroke prevention in atrial fibrillation: current status and perspectives. Eur Heart J [Internet]. 2024 Jul 19 [cited 2024 Sep 17];45(32). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39027946\/","DOI":"10.1093\/eurheartj\/ehae398"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"13. \tOliva A, Ioppolo AM, Chiarito M, Cremonesi A, Azzano A, Miccich\u00e8 E, et al. Left Atrial Appendage Closure Compared With Oral Anticoagulants for Patients With Atrial Fibrillation: A Systematic Review and Network Meta-Analysis. J Am Heart Assoc [Internet]. 2024 Aug 20 [cited 2024 Sep 24];13(16). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39119987\/","DOI":"10.1161\/JAHA.124.034815"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"14. \tKebernik J, Jose J, Abdel-Wahab M, St\u00f6cker B, Geist V, Richardt G. Safety and Efficacy of Left Atrial Appendage Closure with the Amplatzer Cardiac Plug in Very High Stroke and Bleeding Risk Patients with Non-Valvular Atrial Fibrillation. Cardiol Ther [Internet]. 2015 Dec 1 [cited 2024 Sep 24];4(2):167\ufffd77. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26563411\/","DOI":"10.1007\/s40119-015-0053-z"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"15. \tKarim N, Ho SY, Nicol E, Li W, Zemrak F, Markides V, et al. The left atrial appendage in humans: structure, physiology, and pathogenesis. Europace [Internet]. 2020 Jan 1 [cited 2024 Sep 17];22(1):5\ufffd18. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31578542\/","DOI":"10.1093\/europace\/euz212"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"16. \tGlikson M, Wolff R, Hindricks G, Mandrola J, Camm AJ, Lip GYH, et al. EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update. EuroIntervention [Internet]. 2020 Jan 1 [cited 2024 Sep 24];15(13):1133\ufffd80. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31474583\/","DOI":"10.4244\/EIJY19M08_01"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"17. \tHolmes DR, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, et al. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol [Internet]. 2014 Jul 8 [cited 2024 Sep 17];64(1):1\ufffd12. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/24998121\/","DOI":"10.1016\/j.jacc.2014.04.029"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"18. \tReddy VY, Doshi SK, Sievert H, Buchbinder M, Neuzil P, Huber K, et al. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial. Circulation [Internet]. 2013 Feb 12 [cited 2024 Sep 17];127(6):720\ufffd9. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/23325525\/","DOI":"10.1161\/CIRCULATIONAHA.112.114389"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"19. \tReddy VY, Doshi SK, Kar S, Gibson DN, Price MJ, Huber K, et al. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials. J Am Coll Cardiol [Internet]. 2017 Dec 19 [cited 2024 Sep 17];70(24):2964\ufffd75. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29103847\/","DOI":"10.1016\/j.jacc.2017.10.021"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"20. \tOsmancik P, Herman D, Neuzil P, Hala P, Taborsky M, Kala P, et al. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation. J Am Coll Cardiol [Internet]. 2020 Jun 30 [cited 2024 Sep 17];75(25):3122\ufffd35. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32586585\/","DOI":"10.1016\/j.jacc.2020.04.067"},{"key":"ref21","unstructured":"21. \tWazni OM, Saliba WI, Nair DG, Marijon E, Schmidt B, Hounshell T, et al. Left Atrial Appendage Closure after Ablation for Atrial Fibrillation. N Engl J Med [Internet]. 2024 Nov 16 [cited 2024 Nov 23]; Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39555822\/"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"22. \tZheng Y, Zhang N, Tse G, Li G, Lip GYH, Liu T. Co-administered oral anticoagulants with nonsteroidal anti-inflammatory drugs and the risk of bleeding: A systematic review and meta-analysis. Thromb Res [Internet]. 2023 Dec 1 [cited 2024 Dec 9];232:15\ufffd26. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39492109\/","DOI":"10.1016\/j.thromres.2023.10.011"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"23. \tLanas A, Carrera-Lasfuentes P, Arguedas Y, Garc\u00eda S, Bujanda L, Calvet X, et al. Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants. Clin Gastroenterol Hepatol [Internet]. 2015 May 1 [cited 2024 Sep 24];13(5):906-912.e2. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/25460554\/","DOI":"10.1016\/j.cgh.2014.11.007"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"24. \tKim KO, Kozarek R, Gluck M, Ross A, Lin OS. Changes in Lower Gastrointestinal Bleeding Presentation, Management, and Outcomes Over a 10-Year Span. J Clin Gastroenterol [Internet]. 2019 Nov 1 [cited 2024 Oct 28];53(10):e463\ufffd7. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31593973\/","DOI":"10.1097\/MCG.0000000000001223"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"25. \tBarkun AN, Almadi M, Kuipers EJ, Laine L, Sung J, Tse F, et al. Management of Nonvariceal Upper Gastrointestinal Bleeding: Guideline Recommendations From the International Consensus Group. Ann Intern Med [Internet]. 2019 Dec 3 [cited 2024 Dec 9];171(11):805\ufffd22. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31634917\/","DOI":"10.7326\/M19-1795"},{"key":"ref26","unstructured":"26. \tOakland K, Guy R, Uberoi R, Hogg R, Mortensen N, Murphy MF, et al. Acute lower GI bleeding in the UK: patient characteristics, interventions and outcomes in the first nationwide audit. Gut [Internet]. 2018 Apr 1 [cited 2024 Oct 28];67(4):654\ufffd62. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28148540\/"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"27. \tPennazio M, Rondonotti E, Despott EJ, Dray X, Keuchel M, Moreels T, et al. Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel disorders: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2022. Endoscopy [Internet]. 2023 Jan 1 [cited 2024 Dec 12];55(1):58\ufffd95. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36423618\/","DOI":"10.1055\/a-1973-3796"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"28. \tHirata I, Tsuboi A, Matsubara Y, Sumioka A, Takasago T, Tanaka H, et al. Long-term outcomes of patients with obscure gastrointestinal bleeding after negative capsule endoscopy. J Gastroenterol Hepatol [Internet]. 2024 Jan 1 [cited 2024 Dec 12];39(1):165\ufffd71. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37837361\/","DOI":"10.1111\/jgh.16379"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"29. \tWetwittayakhlang P, Wonglhow J, Netinatsunton N, Chamroonkul N, Piratvisuth T. Re-bleeding and its predictors after capsule endoscopy in patients with obscure gastrointestinal bleeding in long-term follow-up. BMC Gastroenterol [Internet]. 2019 Dec 16 [cited 2024 Dec 12];19(1). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31842770\/","DOI":"10.1186\/s12876-019-1137-3"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"30. \tOtani K, Shimada S, Watanabe T, Nadatani Y, Higashimori A, Ominami M, et al. Long-term rebleeding rate and predictive factors of rebleeding after capsule endoscopy in patients with obscure GI bleeding. Gastrointest Endosc [Internet]. 2022 Dec 1 [cited 2024 Dec 12];96(6):956-969.e3. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35850171\/","DOI":"10.1016\/j.gie.2022.07.012"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Benamouzig R, Guenoun M, Deutsch D, Fauchier L. Review Article: Gastrointestinal Bleeding Risk with Direct Oral Anticoagulants. Cardiovasc drugs Ther [Internet]. 2022 Oct 1 [cited 2024 Sep 24];36(5):973\ufffd89. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34143317\/","DOI":"10.1007\/s10557-021-07211-0"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"32. \tGu ZC, Wei AH, Zhang C, Wang XH, Zhang L, Shen L, et al. Risk of Major Gastrointestinal Bleeding With New vs Conventional Oral Anticoagulants: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol [Internet]. 2020 Apr 1 [cited 2024 Sep 24];18(4):792-799.e61. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31195162\/","DOI":"10.1016\/j.cgh.2019.05.056"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"33. \tKang DS, Yang PS, Kim D, Jang E, Yu HT, Kim TH, et al. Racial Differences in Bleeding Risk: An Ecological Epidemiological Study Comparing Korea and United Kingdom Subjects. Thromb Haemost [Internet]. 2024 [cited 2024 Dec 9];124(9). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/38359877\/","DOI":"10.1055\/a-2269-1123"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"34. \tSchulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost [Internet]. 2005 Apr [cited 2024 Dec 15];3(4):692\ufffd4. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/15842354\/","DOI":"10.1111\/j.1538-7836.2005.01204.x"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"35. \tColeman CI, Sobieraj DM, Winkler S, Cutting P, Mediouni M, Alikhanov S, et al. Effect of pharmacological therapies for stroke prevention on major gastrointestinal bleeding in patients with atrial fibrillation. Int J Clin Pract [Internet]. 2012 Jan [cited 2024 Oct 28];66(1):53\ufffd63. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/22093613\/","DOI":"10.1111\/j.1742-1241.2011.02809.x"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"36. \tMiller CS, Dorreen A, Martel M, Huynh T, Barkun AN. Risk of Gastrointestinal Bleeding in Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol [Internet]. 2017 Nov 1 [cited 2024 Oct 28];15(11):1674-1683.e3. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28458008\/","DOI":"10.1016\/j.cgh.2017.04.031"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"37. \tIngason AB, Hreinsson JP, \u00c1g\u00fastsson AS, Lund SH, Rumba E, P\u00e1lsson DA, et al. Rivaroxaban Is Associated With Higher Rates of Gastrointestinal Bleeding Than Other Direct Oral Anticoagulants?: A Nationwide Propensity Score-Weighted Study. Ann Intern Med [Internet]. 2021 Nov 1 [cited 2024 Oct 28];174(11):1493\ufffd502. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34633836\/","DOI":"10.7326\/M21-1474"},{"key":"ref38","unstructured":"38. \tConnolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med [Internet]. 2009 Sep 17 [cited 2024 Oct 28];361(12):1139\ufffd51. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/19717844\/"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"39. \tGiugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med [Internet]. 2013 Nov 28 [cited 2024 Oct 28];369(22):2093\ufffd104. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/24251359\/","DOI":"10.1056\/NEJMoa1310907"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"40. \tPatel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med [Internet]. 2011 Sep 8 [cited 2024 Dec 12];365(10):883\ufffd91. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/21830957\/","DOI":"10.1056\/NEJMoa1009638"},{"key":"ref41","unstructured":"41. \tGranger CB, Alexander JH, McMurray JJV, Lopes RD, Hylek EM, Hanna M, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med [Internet]. 2011 Sep 15 [cited 2024 Dec 12];365(11):981\ufffd92. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/21870978\/"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"42. \tArchontakis Barakakis P, Kokkinidis DG, Li W, Nagraj S, Peppas S, Kladas M, et al. Safety of Direct Oral Anticoagulants for Gastrointestinal Hemorrhage in Patients With Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-analysis of Real-world Studies. J Clin Gastroenterol [Internet]. 2023 Nov 15 [cited 2024 Dec 12];57(10):1045\ufffd53. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36730651\/","DOI":"10.1097\/MCG.0000000000001796"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"43. \tLip GYH, Keshishian A V., Zhang Y, Kang A, Dhamane AD, Luo X, et al. Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With High Risk of Gastrointestinal Bleeding. JAMA Netw open [Internet]. 2021 Aug 16 [cited 2024 Dec 9];4(8):E2120064. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34398204\/","DOI":"10.1001\/jamanetworkopen.2021.20064"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"44. \tL\u00f3pez-M\u00ednguez JR, Nogales-Asensio JM, Infante De Oliveira E, De Gama Ribeiro V, Ruiz-Salmer\u00f3n R, Arzamendi-Aizpurua D, et al. Long-term Event Reduction After Left Atrial Appendage Closure. Results of the Iberian Registry II. Rev Esp Cardiol (Engl Ed) [Internet]. 2019 Jun [cited 2024 Sep 17];72(6):449\ufffd55. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29754808\/","DOI":"10.1016\/j.rec.2018.03.017"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"45. \tAl-Hussainy N, Kragholm KH, Lundbye-Christensen S, Torp-Pedersen C, Pareek M, Therkelsen SK, et al. Gastrointestinal bleeding with direct oral anticoagulants in patients with atrial fibrillation and anaemia. Thromb Res [Internet]. 2023 Dec 1 [cited 2024 Dec 9];232:62\ufffd9. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37939578\/","DOI":"10.1016\/j.thromres.2023.10.013"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"46. \tSanz Segura P, Jimeno S\u00e1nchez J, Arbon\u00e9s-Mainar JM, S\u00e1nchez-Rubio Lezcano J, Galache Osuna G, Bernal Monterde V. Percutaneous left atrial appendage closure in patients with gastrointestinal bleeding associated with oral anticoagulants. Scand J Gastroenterol [Internet]. 2023 [cited 2024 Sep 17];58(12):1547\ufffd54. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37489111\/","DOI":"10.1080\/00365521.2023.2239973"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"47. \tGonzalez-Gonzalez L, Calm A, Ma\u00f1osa M, Baz\u00e1n V, Borrellas A, Carrillo X, et al. Impact of left atrial appendage closure in patients on anticoagulation for atrial fibrillation and recurrent or chronic gastrointestinal bleeding. Gastroenterol Hepatol [Internet]. 2023 Oct 1 [cited 2024 Sep 17];46(8):621\ufffd7. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36828118\/","DOI":"10.1016\/j.gastrohep.2023.02.002"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"48. \tZanetto A, Campello E, Senzolo M, Simioni P. The evolving knowledge on primary hemostasis in patients with cirrhosis: A comprehensive review. Hepatology [Internet]. 2024 Feb 1 [cited 2024 Sep 17];79(2):460\ufffd81. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36825598\/","DOI":"10.1097\/HEP.0000000000000349"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"49. \tRoberts LN, Lisman T, Stanworth S, Hernandez-Gea V, Magnusson M, Tripodi A, et al. Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: Guidance from the SSC of the ISTH. J Thromb Haemost [Internet]. 2022 Jan 1 [cited 2024 Dec 9];20(1):39\ufffd47. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34661370\/","DOI":"10.1111\/jth.15562"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"50. \tChokesuwattanaskul R, Thongprayoon C, Bathini T, O\ufffdCorragain OA, Sharma K, Preechawat S, et al. Epidemiology of atrial fibrillation in patients with cirrhosis and clinical significance: a meta-analysis. Eur J Gastroenterol Hepatol [Internet]. 2019 Apr 1 [cited 2024 Sep 17];31(4):514\ufffd9. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30451705\/","DOI":"10.1097\/MEG.0000000000001315"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"51. \tSenzolo M, Garcia-Pagan JC. A major research gap: The use of anticoagulants in cirrhosis. J Hepatol [Internet]. 2023 Dec 1 [cited 2024 Sep 17];79(6):1566\ufffd70. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37302580\/","DOI":"10.1016\/j.jhep.2023.06.001"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"52. \tSteensig K, Pareek M, Krarup AL, Sogaard P, Maeng M, Tayal B, et al. Thromboembolism and bleeding in patients with atrial fibrillation and liver disease - A nationwide register-based cohort study: Thromboembolism and bleeding in liver disease. Clin Res Hepatol Gastroenterol [Internet]. 2022 Oct 1 [cited 2024 Dec 9];46(8). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35609823\/","DOI":"10.1016\/j.clinre.2022.101952"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"53. \tProietti M, Marzona I, Vannini T, Colacioppo P, Tettamanti M, Foresta A, et al. Impact of liver disease on oral anticoagulant prescription and major adverse events in patients with atrial fibrillation: analysis from a population-based cohort study. Eur Hear journal Cardiovasc Pharmacother [Internet]. 2021 Apr 1 [cited 2024 Dec 9];7(FI1):F84\ufffd92. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32129845\/","DOI":"10.1093\/ehjcvp\/pvaa015"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"54. \tPereira Portela C, Gautier LA, Zermatten MG, Fraga M, Moradpour D, Bertaggia Calderara D, et al. Direct oral anticoagulants in cirrhosis: Rationale and current evidence. JHEP reports  Innov Hepatol [Internet]. 2024 Aug 1 [cited 2024 Dec 28];6(8). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39100819\/","DOI":"10.1016\/j.jhepr.2024.101116"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"55. \tSimon TG, Schneeweiss S, Singer DE, Sreedhara SK, Lin KJ. Prescribing Trends of Oral Anticoagulants in US Patients With Cirrhosis and Nonvalvular Atrial Fibrillation. J Am Heart Assoc [Internet]. 2023 Feb 7 [cited 2024 Sep 17];12(3). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36625307\/","DOI":"10.1161\/JAHA.122.026863"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"56. \tSerper M, Weinberg EM, Cohen JB, Reese PP, Taddei TH, Kaplan DE. Mortality and Hepatic Decompensation in Patients With Cirrhosis and Atrial Fibrillation Treated With Anticoagulation. Hepatology [Internet]. 2021 Jan 1 [cited 2024 Dec 9];73(1):219\ufffd32. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32267547\/","DOI":"10.1002\/hep.31264"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"57. \tHan H, Qin Y, Yu Y, Wei X, Guo H, Ruan Y, et al. Atrial fibrillation in hospitalized patients with end-stage liver disease: temporal trends in prevalence and outcomes. Liver Int [Internet]. 2020 Mar 1 [cited 2024 Dec 9];40(3):674\ufffd84. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31705572\/","DOI":"10.1111\/liv.14291"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"58. \tLawal OD, Aronow HD, Shobayo F, Hume AL, Taveira TH, Matson KL, et al. Comparative Effectiveness and Safety of Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and Chronic Liver Disease: A Nationwide Cohort Study. Circulation [Internet]. 2023 Mar 7 [cited 2024 Sep 17];147(10):782\ufffd94. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36762560\/","DOI":"10.1161\/CIRCULATIONAHA.122.060687"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"59. \tLi Z, Xu W, Wang L, Chai L, Ageno W, Romeiro FG, et al. Risk of Bleeding in Liver Cirrhosis Receiving Direct Oral Anticoagulants: A Systematic Review and Meta-analysis. Thromb Haemost [Internet]. 2023 Mar 16 [cited 2024 Oct 28];123(11):1072\ufffd88. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37336474\/","DOI":"10.1055\/s-0043-1770100"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"60. \tMir T, Rawasia WF, Uddin M, Sheikh M, Munir MB, Balla S. Left atrial appendage closure device outcomes among cirrhosis patients with atrial fibrillation: a United States National Cohort Study. Europace [Internet]. 2023 Apr 1 [cited 2024 Sep 17];25(4):1408\ufffd14. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36857522\/","DOI":"10.1093\/europace\/euad004"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"61. \tSundhu MA, Waheed TA, Nasir U, Handa R, Dever R, Macciocca M, et al. Thirty-Day Readmissions After Percutaneous Left Atrial Appendage Occlusion: Insights from the Nationwide Readmissions Database. Curr Probl Cardiol [Internet]. 2022 Dec 1 [cited 2024 Dec 14];47(12). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34610349\/","DOI":"10.1016\/j.cpcardiol.2021.101006"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"62. \tCalvert P, Gupta D. Left atrial appendage occlusion in patients with cirrhotic liver disease: the importance of patient selection. Europace [Internet]. 2023 Apr 1 [cited 2024 Nov 11];25(4):1315\ufffd7. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36857533\/","DOI":"10.1093\/europace\/euad032"},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"63. \tJoglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, et al. 2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation [Internet]. 2024 Jan 2 [cited 2024 Sep 24];149(1):E1\ufffd156. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/38033089\/","DOI":"10.1161\/CIR.0000000000001263"},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"64. \tTapaskar N, Pang A, Werner DA, Sengupta N. Resuming Anticoagulation Following Hospitalization for Gastrointestinal Bleeding Is Associated with Reduced Thromboembolic Events and Improved Mortality: Results from a Systematic Review and Meta-Analysis. Dig Dis Sci [Internet]. 2021 Feb 1 [cited 2024 Dec 12];66(2):554\ufffd66. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32279174\/","DOI":"10.1007\/s10620-020-06248-9"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"65. \tProietti M, Romiti GF, Romanazzi I, Farcomeni A, Staerk L, Nielsen PB, et al. Restarting oral anticoagulant therapy after major bleeding in atrial fibrillation: A systematic review and meta-analysis. Int J Cardiol [Internet]. 2018 Jun 15 [cited 2024 Sep 17];261:84\ufffd91. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29572080\/","DOI":"10.1016\/j.ijcard.2018.03.053"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"66. \tQureshi W, Mittal C, Patsias I, Garikapati K, Kuchipudi A, Cheema G, et al. Restarting anticoagulation and outcomes after major gastrointestinal bleeding in atrial fibrillation. Am J Cardiol [Internet]. 2014 Feb 15 [cited 2024 Sep 24];113(4):662\ufffd8. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/24355310\/","DOI":"10.1016\/j.amjcard.2013.10.044"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"67. \tAhn HJ, Lee SR, Choi EK, Rhee TM, Kwon S, Oh S, et al. Protective effect of proton-pump inhibitor against gastrointestinal bleeding in patients receiving oral anticoagulants: A systematic review and meta-analysis. Br J Clin Pharmacol [Internet]. 2022 Nov 1 [cited 2024 Sep 17];88(11):4676\ufffd87. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35921204\/","DOI":"10.1111\/bcp.15478"},{"key":"ref68","doi-asserted-by":"crossref","unstructured":"68. \tKatapadi A, Lakkireddy D. The Post-Left Atrial Appendage Occlusion Antithrombotic Selection Conundrum: Are We There Yet? J Am Coll Cardiol [Internet]. 2024 Sep 3 [cited 2024 Sep 24];84(10):901\ufffd3. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39197979\/","DOI":"10.1016\/j.jacc.2024.07.003"},{"key":"ref69","unstructured":"69. \tLip GYH, Frison L, Halperin JL, Lane DA. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal\/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs\/Alcohol Concomitantly) score. J Am Coll Cardiol [Internet]. 2011 Jan 11 [cited 2024 Dec 14];57(2):173\ufffd80. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/21111555\/"},{"key":"ref70","doi-asserted-by":"crossref","unstructured":"70. \tLaursen SB, Oakland K, Laine L, Bieber V, Marmo R, Redondo-Cerezo E, et al. ABC score: a new risk score that accurately predicts mortality in acute upper and lower gastrointestinal bleeding: an international multicentre study. Gut [Internet]. 2021 Apr 1 [cited 2024 Dec 14];70(4):707\ufffd16. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32723845\/","DOI":"10.1136\/gutjnl-2019-320002"},{"key":"ref71","doi-asserted-by":"crossref","unstructured":"71. \tTeppo K, Lip GYH, Airaksinen KEJ, Halminen O, Haukka J, Putaala J, et al. Comparing CHA2DS2-VA and CHA2DS2-VASc scores for stroke risk stratification in patients with atrial fibrillation: a temporal trends analysis from the retrospective Finnish AntiCoagulation in Atrial Fibrillation (FinACAF) cohort. Lancet Reg Heal Eur [Internet]. 2024 Aug 1 [cited 2024 Dec 9];43. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39171253\/","DOI":"10.1016\/j.lanepe.2024.100967"}],"container-title":["Revista Espa\u00f1ola de Enfermedades Digestivas"],"original-title":[],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T09:32:45Z","timestamp":1768555965000},"score":1,"resource":{"primary":{"URL":"https:\/\/online.reed.es\/fichaArticulo.aspx?iarf=674298285463736-792156343580165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":71,"URL":"https:\/\/doi.org\/10.17235\/reed.2026.11781\/2025","relation":{},"ISSN":["1130-0108"],"issn-type":[{"value":"1130-0108","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}